ABROCITINIB vs BARICITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ABROCITINIB vs BARICITINIB: Safety Overview
| Metric | ABROCITINIB | BARICITINIB |
|---|---|---|
| Total FAERS Reports | 3,170 | 8,108 |
| Deaths Reported | 57 | 717 |
| Death Rate | 1.8% | 8.8% |
| Hospitalizations | 329 | 2,498 |
| Average Patient Age | 48.5 yrs | 58.2 yrs |
| % Female Patients | 53.9% | 67.9% |
| FDA Approval Date | Jan 14, 2022 | Aug 8, 2025 |
| Manufacturer | U.S. Pharmaceuticals | Eli Lilly and Company |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |